Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q4 FY26
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Discovery themes featuring this stock
Discovery themes featuring this stockYatharth Hospital & Trauma Care Services Ltd (YATHARTH) is currently trading at 833.40 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Yatharth Hospital & Trauma Care Services Limited operates a network of super‑speciality tertiary and quaternary hospitals concentrated in the Delhi NCR and select North Indian markets, delivering complex specialties such as oncology, cardiology, neurosciences, robotic surgeries and organ transplants across eight hospitals and a reported bed capacity above 2,550 as of Q3 FY26. Q3 FY26 was the company’s strongest quarter with revenue of Rs.3,205 million (+46% YoY) and EBITDA of Rs.742 million; management reports an adjusted EBITDA margin of 29.2% excluding ramp‑up losses from New Delhi and Faridabad Sec‑20, indicating meaningful operating leverage from ARPOB gains and higher super‑speciality mix. The company has been acquisitive and capital intensive: Agra was acquired for Rs.260 crore and integrated from February 2026, while management has outlined a ~Rs.1,500 crore capex plan to reach ~5,000 beds using mixed models, implying capex per bed of roughly Rs.60–90 lakh depending on asset intensity and asset‑light share. Operational metrics are improving: blended occupancy stood at 67% and ARPOB at Rs.33,744 in Q3 FY26, supported by Noida Extension’s Rs.44k ARPOB; management is also building medical value travel channels and expects Jewar airport to enhance cross‑border patient flows, creating a non‑domestic growth vector.
Over the past 52 weeks, Yatharth Hospital & Trauma Care Services Ltd has traded between a low of ₹484.90 and a high of ₹889.80. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Yatharth Hospital & Trauma Care Services Ltd has a market capitalization of approximately 8,081.24. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Yatharth Hospital & Trauma Care Services Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 45.88 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 8,081.24 Cr, Yatharth Hospital & Trauma Care Services Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Yatharth Hospital & Trauma Care Services Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Yatharth Hospital & Trauma Care Services Ltd is 45.88. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Standalone net sales (income from operations) were ₹163.87 crore in Q4 FY26, up from ₹111.99 crore in Q4 FY25.
The feed states the share price is ₹809.8 as of 26 May, 2026, while another table lists a current share price reference of ₹820.55.
FY26 revenue rose 36% year-on-year to ₹1,207.2 crore (₹12,072 million) for the year ended March 31, 2026.
In the March 2026 quarter, net sales were Rs 341.56 crore and consolidated net profit was Rs 47.52 crore, as per the provided results summary.
Earnings Call Transcript
Yatharth Hospitals filed the Q4 FY26 earnings call transcript reporting consolidated revenue of INR 12,072 mn (+36% YoY) and EBITDA of INR 2,921 mn (+30% YoY); highlighted new hospital ramp-ups, Agra integration and Gurugram acquisition (~INR 100cr).
Earnings Transcript
Filed the Q4 FY26 earnings conference call transcript (quarter & year ended Mar 31, 2026) with NSE/BSE and posted on the company website; transcript cites consolidated revenue ~INR 12,072m (+36% YoY), EBITDA ~INR 2,921m (+30% YoY) and expansion updates.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
293.60 | 12,628 Cr | 49.79 | 6.28 | 0.00 | 12.77 | 17.33 | 9.55 | ||
635.90 | 9,464 Cr | 687.76 | 7.10 | 0.00 | 2.90 | 7.81 | 0.58 | ||
1334.85 | 8,763 Cr | 45.17 | 5.68 | 0.07 | 12.56 | 13.77 | 8.15 | ||
840.00 | 8,081 Cr | 45.88 | 4.54 | 0.00 | 9.85 | 11.09 | 7.50 | ||
5748.75 | 6,289 Cr | 25.73 | 4.77 | 0.26 | 18.53 | 20.76 | 11.83 | ||
258.95 | 4,095 Cr | 39.52 | 4.73 | 0.17 | 11.09 | 13.95 | 7.26 | ||
392.85 | 3,601 Cr | 19.61 | 4.86 | 1.02 | 24.80 | 32.39 | 18.52 | ||
| Median: 7 Co. | — | 635.90 | 8,081 Cr | 45.17 | 4.86 | 0.07 | 12.56 | 13.95 | 8.15 |
Bearish
5
Neutral
7
Bullish
2
Bearish
6
Neutral
7
Bullish
33
Bearish
1
Neutral
0
Bullish
31
Yatharth Hospital & Trauma Care Services Limited operates a network of super‑speciality tertiary and quaternary hospitals concentrated in the Delhi NCR and select North Indian markets, delivering complex specialties such as oncology, cardiology, neurosciences, robotic surgeries and organ transplants across eight hospitals and a reported bed capacity above 2,550 as of Q3 FY26.
Q3 FY26 was the company’s strongest quarter with revenue of Rs.3,205 million (+46% YoY) and EBITDA of Rs.742 million; management reports an adjusted EBITDA margin of 29.2% excluding ramp‑up losses from New Delhi and Faridabad Sec‑20, indicating meaningful operating leverage from ARPOB gains and higher super‑speciality mix.
The company has been acquisitive and capital intensive: Agra was acquired for Rs.260 crore and integrated from February 2026, while management has outlined a ~Rs.1,500 crore capex plan to reach ~5,000 beds using mixed models, implying capex per bed of roughly Rs.60–90 lakh depending on asset intensity and asset‑light share.
Operational metrics are improving: blended occupancy stood at 67% and ARPOB at Rs.33,744 in Q3 FY26, supported by Noida Extension’s Rs.44k ARPOB; management is also building medical value travel channels and expects Jewar airport to enhance cross‑border patient flows, creating a non‑domestic growth vector.
Healthcare Services
Hospital
8,030 Cr
Low Risk
45.6
59.2
1.1
4.5
889.80
484.90
Sales CAGR
Profit CAGR
ROE
ROCE
